Validated tool for early prediction of intensive care unit admission in COVID-19 patients

被引:0
|
作者
Hao-Fan Huang [1 ]
Yong Liu [2 ]
Jin-Xiu Li [3 ]
Hui Dong [4 ]
Shan Gao [1 ]
Zheng-Yang Huang [1 ]
Shou-Zhi Fu [4 ]
Lu-Yu Yang [4 ]
Hui-Zhi Lu [4 ]
Liao-You Xia [4 ]
Song Cao [4 ]
Yi Gao [1 ]
Xia-Xia Yu [1 ]
机构
[1] School of Biomedical Engineering, Health Science Center, Shenzhen University
[2] Expert Panel of Shenzhen 2019-nCoV Pneumonia, Shenzhen Hospital, Southern Medical University
[3] Department of Critical Care Medicine, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology
[4] Department of ICU/Emergency, Wuhan Third Hospital, Wuhan University
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The novel coronavirus disease 2019(COVID-19) pandemic is a global threat caused by the severe acute respiratory syndrome coronavirus-2.AIM To develop and validate a risk stratification tool for the early prediction of intensive care unit(ICU) admission among COVID-19 patients at hospital admission.METHODS The training cohort included COVID-19 patients admitted to the Wuhan Third Hospital. We selected 13 of 65 baseline laboratory results to assess ICU admission risk, which were used to develop a risk prediction model with the random forest(RF) algorithm. A nomogram for the logistic regression model was built based on six selected variables. The predicted models were carefully calibrated, and the predictive performance was evaluated and compared with two previously published models.RESULTS There were 681 and 296 patients in the training and validation cohorts, respectively. The patients in the training cohort were older than those in the validation cohort(median age: 63.0 vs 49.0 years, P < 0.001), and the percentages of male gender were similar(49.6% vs 49.3%, P = 0.958). The top predictors selected in the RF model were neutrophil-to-lymphocyte ratio, age, lactate dehydrogenase, C-reactive protein, creatinine, D-dimer, albumin, procalcitonin, glucose, platelet, total bilirubin, lactate and creatine kinase. The accuracy, sensitivity and specificity for the RF model were 91%, 88% and 93%, respectively, higher than those for the logistic regression model. The area under the receiver operating characteristic curve of our model was much better than those of two other published methods(0.90 vs 0.82 and 0.75). Model A underestimated risk of ICU admission in patients with a predicted risk less than 30%, whereas the RF risk score demonstrated excellent ability to categorize patients into different risk strata. Our predictive model provided a larger standardized net benefit across the major high-risk range compared with model A.CONCLUSION Our model can identify ICU admission risk in COVID-19 patients at admission, who can then receive prompt care, thus improving medical resource allocation.
引用
收藏
页码:8388 / 8403
页数:16
相关论文
共 50 条
  • [41] Long-term mortality of elderly patients after intensive care unit admission for COVID-19
    Guillon, Antoine
    Laurent, Emeline
    Godillon, Lucile
    Kimmoun, Antoine
    Grammatico-Guillon, Leslie
    [J]. INTENSIVE CARE MEDICINE, 2021, 47 (06) : 710 - 712
  • [42] Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission
    Ortillon, Marine
    Coudereau, Remy
    Cour, Martin
    Rimmele, Thomas
    Godignon, Marine
    Gossez, Morgane
    Yonis, Hodane
    Argaud, Laurent
    Lukaszewicz, Anne-Claire
    Venet, Fabienne
    Monneret, Guillaume
    [J]. CYTOMETRY PART A, 2021, 99 (05) : 466 - 471
  • [43] ELEVATED SERUM AMINOTRANSFERASE LEVELS AT PRESENTATION ARE ASSOCIATED WITH INTENSIVE CARE UNIT ADMISSION IN PATIENTS WITH COVID-19
    Yan, Wei
    Jennings, Joseph J.
    Montero, Alex R.
    [J]. HEPATOLOGY, 2020, 72 : 272A - 273A
  • [44] Rheumatic diseases in intensive care unit patients with COVID-19
    Moiseev, Sergey
    Avdeev, Sergey
    Brovko, Michail
    Yavorovskiy, Andrey
    Novikov, Pavel I.
    Umbetova, Karina
    Akulkina, Larisa
    Tsareva, Natal'ya
    Fomin, Victor
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02)
  • [45] Experiences of intensive care unit nurses with COVID-19 patients
    Conz, Claudete Aparecida
    Souza Braga, Vanessa Augusta
    Vasconcelos, Rosianne
    Ribeiro da Silva Machado, Flavia Helena
    Pinto de Jesus, Maria Cristina
    Barbosa Merighi, Miriam Aparecida
    [J]. REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2021, 55
  • [46] Delirium in patients with COVID-19 treated in the intensive care unit
    Lee, Jae Hoon
    Han, Won Ho
    Chun, June Young
    Choi, Young Ju
    Han, Mi Ra
    Kim, Jee Hee
    [J]. PLOS ONE, 2023, 18 (11):
  • [47] EVALUATION OF TOCILIZUMAB IN PATIENTS WITH COVID-19 IN THE INTENSIVE CARE UNIT
    Gillenwater, Betsy
    Artman, Katherine
    Wingler, Mary Joyce
    Wilhelm, Andrew
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 103 - 103
  • [48] Heparin resistance in COVID-19 patients in the intensive care unit
    White, D.
    MacDonald, S.
    Bull, T.
    Hayman, M.
    de Monteverde-Robb, R.
    Sapsford, D.
    Lavinio, A.
    Varley, J.
    Johnston, A.
    Besser, M.
    Thomas, W.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) : 287 - 291
  • [49] Intensive Care Admission and Early Neuro-Rehabilitation. Lessons for COVID-19?
    Pincherle, Alessandro
    Joehr, Jane
    Pancini, Lisa
    Leocani, Letizia
    Dalla Vecchia, Laura
    Ryvlin, Philippe
    Schiff, Nicholas D.
    Diserens, Karin
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [50] COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission
    Toprak, O. Baydar
    Akpolat, T.
    Uzun, O.
    Deniz, P. Pinar
    Kokturk, N.
    Varol, A.
    Guzel, E.
    Ercelik, M.
    Gultekin, O.
    Guner, R.
    Turan, S.
    Bekta, S. Goebulut
    Coskun, N.
    Bakan, N.
    Yakar, M. Nuri
    Kutsoylu, O. Eren
    Ergan, B.
    Baris, S. Argun
    Basyigit, I
    Boyaci, H.
    Cetinkaya, F.
    Colak, H.
    Aykac, N.
    Ketencioglu, B. Baran
    Yuce, Z. Ture
    Isik, S. Akkaya
    Yilmaz, E. Serap
    Karaoglanoglu, S.
    Safgi, S. Berik
    Ozkan, G.
    Kose, N.
    Kizilirmak, D.
    Havlucu, Y.
    Nural, S.
    Kerget, F.
    Sunal, Oe.
    Yuksel, A.
    Dursun, Z. Bestepe
    Deveci, F.
    Kuluozturk, M.
    Ataoglu, O.
    Dursun, M.
    Keskin, S.
    Sezgin, M. Emin
    Sezgin, E. n. Aktepe
    Eser, F.
    Akyildiz, L.
    Almaz, M. Selim
    Kayaaslan, B.
    Hasanoglu, I.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (05) : 2132 - 2142